Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to review eligibility criteria for Continuous Glucose Monitoring for people with Type 2 diabetes.

Improving access to diabetes technologies is a priority for NHS England, which uses routine data from the National Diabetes Audit (NDA) to help integrated care boards and providers benchmark themselves and target improvements.

The NDA 2025/26 reports that 64% of people registered as living with type 1 diabetes and eligible for Continuous Glucose Monitoring (CGM) had access to the technology and 65% of people registered as living with type 2 diabetes and eligible for CGM had access to the technology.

The eligibility criteria for CGM amongst type 2 diabetics are set in guidance published by the National Institute for Health and Care Excellence (NICE), available at the following link:

https://www.nice.org.uk/guidance/NG28

NICE is an independent body with its own processes for reviewing and updating its guidance taking account of the best available evidence of both clinical and cost effectiveness

A new diabetes technology dashboard is in development, for publication in 2026. This will allow health systems and providers to better understand access to technology and target improvement efforts, to support higher uptake of CGM for those eligible.